Suppr超能文献

社区获得性肺炎住院患者常规微生物诊断的价值有限。

Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.

作者信息

Lidman Christer, Burman Lars G, Lagergren Asa, Ortqvist Ake

机构信息

Division of Infectious Diseases, University Hospital Huddinge, Stockholm, Sweden.

出版信息

Scand J Infect Dis. 2002;34(12):873-9. doi: 10.1080/0036554021000026967.

Abstract

Current guidelines recommend microbiological diagnostic procedures as a part of the management of patients hospitalized for community-acquired pneumonia (CAP), but the value of such efforts has been questioned. Patients hospitalized for CAP were studied retrospectively, focusing on the use of aetiological diagnostic methods and their clinical impact. Adult patients, without known human immunodeficiency virus infection, admitted to hospital for CAP during 12 months, were evaluated with regard to the importance of aetiological diagnosis for tailoring antibiotic therapy, antibiotic-associated diarrhoea, Clostridium difficile disease, length of hospital stay and mortality. Of the 605 studied patients, 482 (80%) were subjected to Mycoplasma pneumoniae and/or respiratory virus serology and/or cultures of blood and/or sputum. They had a better prognosis than patients not subjected to microbiological diagnostics (mortality within 3 months was 9% vs 24%, p = 0.001), apparently reflecting differences in general health (e.g. less dementia diagnosis) but not the outcome of diagnostics. A presumptive aetiology was obtained only in 132 of the 482 patients, Streptococcus pneumoniae and M. pneumoniae being the most common agents (in 49 and 36 patients, respectively). Establishing an aetiological diagnosis had no impact on the number of in-hospital changes of therapy, on the proportion of new regimens having a narrower antimicrobial spectrum than the initial one or on the outcome. Therapy was changed to a drug directed specifically against the identified pathogen in only 16 out of these 132 patients and again without any overall improvement in the outcome variables. In a setting with a low frequency of antibiotic-resistant respiratory tract pathogens current routine microbiological diagnostics were found to be of limited value for the clinical management of patients hospitalized for CAP. Improved diagnostics in CAP are urgently needed, as establishing an aetiological diagnosis carries a potential for optimizing the antibiotic therapy.

摘要

当前指南推荐将微生物学诊断程序作为社区获得性肺炎(CAP)住院患者管理的一部分,但这种做法的价值受到了质疑。对因CAP住院的患者进行了回顾性研究,重点关注病因诊断方法的使用及其临床影响。对12个月内因CAP入院、无已知人类免疫缺陷病毒感染的成年患者,评估病因诊断对调整抗生素治疗、抗生素相关性腹泻、艰难梭菌病、住院时间和死亡率的重要性。在605例研究患者中,482例(80%)接受了肺炎支原体和/或呼吸道病毒血清学检查和/或血液和/或痰液培养。他们的预后比未接受微生物学诊断的患者更好(3个月内死亡率为9%对24%,p = 0.001),这显然反映了总体健康状况的差异(如痴呆诊断较少),而非诊断结果的差异。在482例患者中,仅132例获得了推测性病因,肺炎链球菌和肺炎支原体是最常见的病原体(分别为49例和36例)。确立病因诊断对住院期间治疗方案的更改次数、新方案抗菌谱比初始方案更窄的比例或治疗结果均无影响。在这132例患者中,仅16例的治疗改为针对已鉴定病原体的特定药物,同样未使结局变量有任何总体改善。在抗生素耐药呼吸道病原体发生率较低的情况下,发现当前常规微生物学诊断对因CAP住院患者的临床管理价值有限。迫切需要改进CAP的诊断方法,因为确立病因诊断有可能优化抗生素治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验